Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pain drug
Pharma
Vertex narrows development plan for non-opioid pain med Journavx
Vertex is narrowing development plans for Journavx and will specifically pursue a nod in diabetic peripheral neuropathy.
Fraiser Kansteiner
Aug 5, 2025 10:55am
Alvogen recalls fentanyl patches due to possible overdose risk
Feb 3, 2025 12:06pm
Vertex survey delves into current difficulties in pain treatment
Oct 10, 2024 10:25am
Kyowa Kirin offloads mature drugs to Grünenthal in Europe
Nov 28, 2022 11:00am
Heron's Zynrelef hits a rough patch in Q4 as trajectory wobbles
Mar 3, 2022 7:40am
Pacira buys Flexion for $450M to boost pain offerings
Oct 11, 2021 11:21am
